Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - November 2016

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Dequalinium (Fluomizin®) has been accepted for restricted use in the treatment of bacterial vaginosis where the initial treatment is ineffective or not well tolerated.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - November 2016' on Email Share 'SMC Update - November 2016' on Delicious Share 'SMC Update - November 2016' on Digg Share 'SMC Update - November 2016' on Facebook Share 'SMC Update - November 2016' on reddit Share 'SMC Update - November 2016' on StumbleUpon Share 'SMC Update - November 2016' on Twitter

atomic-wealth

No Comments to “SMC Update - November 2016”

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer